Metformin Therapy for PCOS with Dyslipidemia

Introduction to Metformin Dosing

The American College of Cardiology recommends metformin 500mg twice daily (1000mg total daily) for patients with mild PCOS and dyslipidemia, with the option to titrate up to 1.5-2g daily based on metabolic response 1, 2
Metformin is indicated for PCOS patients with features of insulin resistance or metabolic syndrome, regardless of normal blood sugar values, with a typical effective dosing range of 1.5-2g daily 1

Starting at 1000mg daily allows for better gastrointestinal tolerability, and metformin at 1g twice daily for 12 weeks significantly improves hormonal and metabolic parameters in PCOS patients 1
Metformin decreases LDL cholesterol and triglyceride levels, providing cardiovascular benefits beyond glucose control, with even modest weight loss (≥5 pounds) enhancing metformin's metabolic and reproductive effects 1, 2
Metformin is contraindicated if renal function is severely impaired (eGFR <30 mL/min/1.73m²) and not recommended to initiate if eGFR 30-45, with screening for hepatic disease, alcohol abuse, and hypoxemic conditions before starting 3

The American College of Obstetricians and Gynecologists recommends discontinuing metformin before conception and not continuing through the first trimester, as metformin readily crosses the placenta and long-term offspring data show concerning trends 1
Metformin normalizes ovulatory abnormalities in many PCOS patients, potentially improving fertility, and contraception counseling should be provided when starting metformin to avoid unplanned pregnancy 1, 3, 2

The American Heart Association recommends assessing treatment response at 12-16 weeks with weight, lipid panel, and menstrual regularity, and monitoring weight changes every 6-12 months 2, 4
If metformin alone provides insufficient metabolic benefit, consider adding a GLP-1 receptor agonist (liraglutide or semaglutide), which may provide additional benefits for weight reduction and metabolic parameters 5, 3